Continuing Effectiveness of Serogroup A Meningococcal Conjugate Vaccine, Chad, 2013

In 2011, vaccination with a serogroup A meningococcal polysaccharide conjugate vaccine was implemented in 3 of 23 regions in Chad. Cases of meningitis declined dramatically in vaccinated areas, but an epidemic continued in the rest of Chad. In 2012, the remaining Chad population was vaccinated, and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Emerging infectious diseases Jg. 21; H. 1; S. 115 - 118
Hauptverfasser: Gamougam, Kadidja, Daugla, Doumagoum M., Toralta, Jacques, Ngadoua, Cyriaque, Fermon, Florence, Page, Anne-Laure, Djingarey, Mamoudou H., Caugant, Dominique A., Manigart, Olivier, Trotter, Caroline L., Stuart, James M., Greenwood, Brian M.
Format: Journal Article
Sprache:Englisch
Veröffentlicht: United States U.S. National Center for Infectious Diseases 01.01.2015
Centers for Disease Control and Prevention
Schlagworte:
ISSN:1080-6040, 1080-6059, 1080-6059
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:In 2011, vaccination with a serogroup A meningococcal polysaccharide conjugate vaccine was implemented in 3 of 23 regions in Chad. Cases of meningitis declined dramatically in vaccinated areas, but an epidemic continued in the rest of Chad. In 2012, the remaining Chad population was vaccinated, and the epidemic was halted.
Bibliographie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1080-6040
1080-6059
1080-6059
DOI:10.3201/eid2101.140256